ASCIA COVID-19 Update
16 March 2020:
In response to the COVID-19 infectious respiratory disease outbreak caused by the most recently discovered coronavirus, ASCIA has developed a number of resources, including a new open access ASCIA webpage dedicated to COVID-19 information. The situation regarding COVID-19 is rapidly changing so the content of the webpage www.allergy.org.au/members/covid-19 is regularly reviewed and updated. It includes links to the following information:
COVID-19 and the ASCIA 2020 Conference
ASCIA is closely monitoring the COVID-19 outbreak in relation to the ASCIA 2020 Conference, scheduled for the first week of September 2020 in Melbourne. Given the rapidly evolving situation in Australia and New Zealand, registrations will be deferred until May 2020 at this stage. ASCIA will take every necessary step to take care of the health and wellbeing of the community, and will continue to provide regular updates as circumstances evolve. If you have any queries, please do not hesitate to contact us.
ASCIA COVID-19 FAQ and other Resources
ASCIA has developed the following information for patients, which is available on the ASCIA COVID-19 webpage www.allergy.org.au/members/covid-19 :
- COVID-19 and Immunodeficiency
- Checklist: Actions to reduce the spread of COVID-19
- COVID-19 Frequently asked questions (FAQ)
COVID-19, Immunodeficiency and Immunosuppression
There is currently limited information available about COVID-19, immunodeficiency and immunosuppression. To expand knowledge in this area and improve patient care, ASCIA is involved in the following initiatives:
- An ASCIA COVID-19 Working Party will be set up to focus on developing resources for health professionals and the community on COVID-19, immunodeficiency and immunosuppression.
- ASCIA members will be invited to participate in online webinars, discussion forums and an International Union of Immunological Societies (IUIS) survey on COVID-19, immunodeficiency and immunosuppression.